PRKN and Parkinsonism: Interestingly, Parkin-deficient mice treated for 3–6 months with repeated, low doses of systemic LPS developed subtle fine-motor deficits and DA neuron loss that were more pronounced than in wildtype controls [122], indicating that enhanced neuronal vulnerability to inflammation may play a role in recessive Parkinsonism.